The average one-year price target for JW Lifescience (KOSE:234080) has been revised to ₩18,360.00 / share. This is an increase of 12.50% from the prior estimate of ₩16,320.00 dated November 14, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of ₩18,180.00 to a high of ₩18,900.00 / share. The average price target represents an increase of 34.41% from the latest reported closing price of ₩13,660.00 / share.
JW Lifescience Maintains 3.66% Dividend Yield
At the most recent price, the company’s dividend yield is 3.66%.
Additionally, the company’s dividend payout ratio is 0.16. The payout ratio tells us how much of a company’s income is paid out in dividends. A payout ratio of one (1.0) means 100% of the company’s income is paid in a dividend. A payout ratio greater than one means the company is dipping into savings in order to maintain its dividend - not a healthy situation. Companies with few growth prospects are expected to pay out most of their income in dividends, which typically means a payout ratio between 0.5 and 1.0. Companies with good growth prospects are expected to retain some earnings in order to invest in those growth prospects, which translates to a payout ratio of zero to 0.5.
What is the Fund Sentiment?
There are 13 funds or institutions reporting positions in JW Lifescience. This is unchanged over the last quarter. Average portfolio weight of all funds dedicated to 234080 is 0.00%, an increase of 9.39%. Total shares owned by institutions decreased in the last three months by 7.92% to 101K shares.
What are Other Shareholders Doing?
DFCEX - Emerging Markets Core Equity Portfolio - Institutional Class holds 57K shares representing 0.36% ownership of the company. In its prior filing, the firm reported owning 59K shares , representing a decrease of 4.78%. The firm decreased its portfolio allocation in 234080 by 4.89% over the last quarter.
DFEM - Dimensional Emerging Markets Core Equity 2 ETF holds 15K shares representing 0.09% ownership of the company. In its prior filing, the firm reported owning 13K shares , representing an increase of 8.16%. The firm increased its portfolio allocation in 234080 by 2.89% over the last quarter.
DFAX - Dimensional World ex U.S. Core Equity 2 ETF holds 7K shares representing 0.04% ownership of the company. No change in the last quarter.
DAADX - Emerging Markets ex China Core Equity Portfolio Institutional Class holds 6K shares representing 0.04% ownership of the company. No change in the last quarter.
DFA INVESTMENT DIMENSIONS GROUP INC - Emerging Markets Social Core Equity Portfolio Shares holds 5K shares representing 0.03% ownership of the company. No change in the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
